Belgium (BE)

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A matter of preference: Taking sides on the Nord Stream 2 gas pipeline project (2022) de Jong M, Van de Graaf T, Haesebrouck T Journal article CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article, Review article CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research. (2022) Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, et al. Journal article Spin-Orbit Photonics in 3D Rotated Anisotropic Materials (2022) Jisha CP, Beeckman J, Nolte S, Alberucci A Conference contribution Corrigendum to ‘Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up’: (Annals of Oncology (2021) 32(3) (309–322), (S0923753420431692), (10.1016/j.annonc.2020.11.014)) (2022) Dimopoulos MA, Moreau P, Terpos E, Mateos MV, Zweegman S, Cook G, Delforge M, et al. Journal article, Erratum EAPC Core Curriculum for Preventive Cardiology (2022) Wilhelm M, Abreu A, Adami PE, Ambrosetti M, Antonopoulou M, Biffi A, Cavarretta E, et al. Journal article Preventing heart failure: A position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (2022) Piepoli MF, Adamo M, Barison A, Bestetti RB, Biegus J, Bohm M, Butler J, et al. Journal article Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. (2022) Cavagna L, Meloni F, Meyer A, Sambataro G, Belliato M, De Langhe E, Cavazzana I, et al. Journal article Keratose sponges in ancient carbonates – A problem of interpretation (2022) Neuweiler F, Kershaw S, Boulvain F, Matysik M, Sendino C, McMenamin M, Munnecke A Journal article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article